Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 68788-7523 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

3da23e7c a3be 46cb b403 da4fb78019db 00

3da23e7c a3be 46cb b403 da4fb78019db 00

Figure 1 - pregabalin fig01

Figure 1 - pregabalin fig01

Figure 2 - pregabalin fig02

Figure 2 - pregabalin fig02

Figure 3 - pregabalin fig03

Figure 3 - pregabalin fig03

Figure 4 - pregabalin fig04

Figure 4 - pregabalin fig04

Figure 5 - pregabalin fig05

Figure 5 - pregabalin fig05

Figure 6 - pregabalin fig06

Figure 6 - pregabalin fig06

Figure 7 - pregabalin fig07

Figure 7 - pregabalin fig07

Figure 9 - pregabalin fig08

Figure 9 - pregabalin fig08

The text shows a graph with the percentage of patients improved in relation to the dosage of Pregabalin, a medication commonly used to treat pain and seizures. The graph demonstrates that patients using higher dosage (450mg) experience a higher rate of improvement in pain compared to those using a lower dosage (300mg) or placebo. The X-axis shows the range of percentage improvement in pain from baseline, while the Y-axis indicates the percentage of patients improved.*

Figure 10 - pregabalin fig09

Figure 10 - pregabalin fig09

The text seems to be a chart displaying the estimated percentage of subjects without LTR (which is not mentioned in the given text) over a period of 120 days, with two different treatments: Progabain and Placebo. The estimated percentages range from 0% to 100%, with increments of 10%. The numbers at the bottom indicate the number of days in the treatment.*

Figure 11 - pregabalin fig10

Figure 11 - pregabalin fig10

Figure 12 - pregabalin fig11

Figure 12 - pregabalin fig11

Percent of subjects improved is being presented in the given text. However, it does not provide any further information or context to understand the scope, purpose or relevance of this information.*

Cockcroft and Gault equation - pregabalin formula

Cockcroft and Gault equation - pregabalin formula

This appears to be a medical formula for calculating CLCT (creatinine clearance using the Cockcroft-Gault formula) in adult patients. The formula involves subtracting the patient's age (in years) from 140, multiplying the result by their weight in kilograms, and then multiplying that value by 0.85 if the patient is female. The final step is to multiply 72 by the patient's serum creatinine level in milligrams per deciliter (mg/dL).*

Chemical Structure - pregabalin str

Chemical Structure - pregabalin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.